Minit Shah
@minitjshah
Followers
48
Following
17
Media
0
Statuses
22
MBBS, MD, DM Medical Oncology (Gold Medalist), Assistant Professor, Solid Tumor, Tata Memorial Centre, Mumbai, India.
Joined January 2023
RT @UrologyTimes: Lower-dose abiraterone demonstrated comparable efficacy to standard-dose abiraterone, positioning itself as a viable alte….
urologytimes.com
Lower-dose abiraterone acetate was found to demonstrate comparable efficacy to standard-dose abiraterone.
0
4
0
RT @SuyogCancer: Big congrats to Dr. Sudeep Gupta & TMH Breast DMG team!.New JCO Global Oncology study of 1,004 HER2+ BC patients on NAT.….
0
9
0
RT @ACTREC_TMC: Indian real-world data (@JCOGO_ASCO) confirms trastuzumab before/after surgery + maintenance enhances survival in HER2-posi….
0
19
0
Victory for our 'Lung Connect' program as Mr Ravi Prakash gets nominated for IASLC award. Congratulations to Tata Memorial Hospital, Solid Tumor Unit 2, and the entire Lung Connect Team!.
0
3
2
Gef vs Gef plus Pemetrexed & Carboplatin Chemotherapy in EGFR-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial. A paper very close to our hearts, true reflection of the hard work of our solid unit 2 department.
0
3
3
RT @ZoyaPeelay: Neoadjuvant chemotherapy in locally advanced Sinonasal Teratocarcinosa. @DrVijayPatil11 @VanitaNo….
0
1
0
A much awaited answer from our Solid Tumour Unit 2 group at Tata Memorial Center. Congratulations Dr Vanita, Dr Vijay, Dr Kumar sir and the entire Solid Tumour Unit 2 team!!!!
0
0
1
RT @CRSTonline: Parween et al. present a pan-cancer analysis of homologous recombination DNA repair pathway genes in the Indian population.….
0
3
0
RT @VanitaNoronha: So proud of the junior most member of our team at @TataMemorial- Dr Minit Shah. Thanks @EvelynWongYT for highlighting th….
0
6
0
RT @EvelynWongYT: Impressive discussion on Inequities in Access to Standards of Cancer Care, using India as an case example by Dr Minit Jal….
0
4
0
RT @ZoyaPeelay: Long term outcomes of phase I/II study of palliative triple metronomic. @DrVijayPatil11.
0
1
0
RT @DrVijayPatil11: Metrnomic adjuvant after definitive CTRT in HNSCC is it usefull? Read our phase 3 study for the answer. @VanitaNoronha….
0
26
0